Tc Biopharm Holdings Plc's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tc Biopharm Holdings Plc's ROA in the fourth quarter of 2024?
Tc Biopharm Holdings Plc recorded a cumulative net loss of $-16 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on assets (ROA) of -94.87%.

However, within the Healthcare sector 969 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from to 5385.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Total Assets Change	59.88 %	129.16 %	-58.01 %	118.87 %	-51.76 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-16	-7	-8	-10	-10
Return On Assets (TTM)	-94.87 %	-47.66 %	-67.43 %	-65.2 %	-83.93 %
TCBP's Total Ranking	# 5385	#	#	#	# 5032
Total Assets (TTM) in million	10	24	7	24	6
Seq. Total Assets Change	-57.45 %	225.52 %	-69.28 %	275.77 %	-39.01 %
Seq. Net Income Change	-	-	-	-	-

TCBP's 5 Years Annual ROA >> Back to TCBP Management Effectiveness >> Compare TCBP ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 158
Sector	# 970
Overall	# 5303

Return On Assets Statistics
High	Average	Low
-12.69 %	-70.17 %	-145.93 %
(Dec 31 2022)		(Dec 31 2024)

Financial Statements
Tc Biopharm Holdings Plc's Assets	$ 10 million	TCBP's Balance sheet
Tc Biopharm Holdings Plc's Income	$ -16 million	Quarterly TCBP's Income Statement
TCBP's Income by Division		See TCBP's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	FY
Y / Y Total Assets Change	-60.71 %	100.19 %	-28.87 %	-	-
Total Assets in million	9	22	11	15	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-12	-6	-1	-14	0
Annual Return On Assets	-141.12 %	-26.95 %	-12.69 %	-88.18 %	-

TCBP's 5 Years Annual ROA >> Back to TCBP Management Effectiveness >> Compare TCBP ROA to its Competitors

More Return On Assets Ratios
TCBP's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TCBP's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TCBP's Competitors
Subscribers only: Roa for Tc Biopharm Holdings Plc's Suppliers
Subscribers only: Return On Assets for TCBP's Customers

You may also want to know
TCBP's Roi	TCBP's Inventory Turnover Ratio	TCBP's Growth Rates	TCBP's Dividend Comparisons
	TCBP's Profitability Ratios	TCBP's Asset Turnover Ratio	TCBP's Dividend Growth
TCBP's Roe	TCBP's Valuation Ratios	TCBP's Financial Strength Ratios	TCBP's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2024, within Healthcare Sector

ROA

Date modified: 2026-09-10T03:41:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.